Alnylam Pharmaceuticals, Inc. (OQ:ALNY)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ALNY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 24th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 20/20 Maraganore John Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -34,765  
May 22/20 May 20/20 Maraganore John Direct Ownership Common Stock S - Open market or private sale -5,013 $144.33
May 22/20 May 20/20 Maraganore John Direct Ownership Common Stock S - Open market or private sale -16,315 $143.46
May 22/20 May 20/20 Maraganore John Direct Ownership Common Stock S - Open market or private sale -13,437 $142.51
May 22/20 May 20/20 Maraganore John Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 34,765 $9.14
May 7/20 May 6/20 Greene Barry E Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -22,265  
May 7/20 May 6/20 Greene Barry E Direct Ownership Common Stock S - Open market or private sale -22,265 $149.99
May 7/20 May 6/20 Greene Barry E Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 22,265 $9.14
May 7/20 May 6/20 Greenstreet Yvonne Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -50,000  
May 7/20 May 6/20 Greenstreet Yvonne Direct Ownership Common Stock S - Open market or private sale -50,000 $150.00
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ALNY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 24th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 20/20 Maraganore John Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -34,765  
May 22/20 May 20/20 Maraganore John Direct Ownership Common Stock S - Open market or private sale -5,013 $144.33
May 22/20 May 20/20 Maraganore John Direct Ownership Common Stock S - Open market or private sale -16,315 $143.46
May 22/20 May 20/20 Maraganore John Direct Ownership Common Stock S - Open market or private sale -13,437 $142.51
May 22/20 May 20/20 Maraganore John Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 34,765 $9.14
May 7/20 May 6/20 Greene Barry E Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -22,265  
May 7/20 May 6/20 Greene Barry E Direct Ownership Common Stock S - Open market or private sale -22,265 $149.99
May 7/20 May 6/20 Greene Barry E Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 22,265 $9.14
May 7/20 May 6/20 Greenstreet Yvonne Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -50,000  
May 7/20 May 5/20 Greenstreet Yvonne Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,561  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ALNY

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
ACADIA Pharmaceuticals (OQ:ACAD)